Breaking News

WuXi STA, Dizal Pharma Ink CMC Alliance

WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

STA Pharmaceutical Co., a subsidiary of WuXi AppTec, and Dizal Pharmaceutical, a biotechnology company, have entered a strategic collaboration under which WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production. WuXi STA will provide integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.   Dizal Pharmaceutical is a research-based joint venture between AstraZeneca and Advanced Manufacturing In...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters